 |
DCA Discussion Forum
Stanely M..

unregistered user
|
Mar-20-07, 02:44 AM (PST) |
|
|
"University Of Alberta"
| |
I am wondering how many doctors and researchers and other universities are interested in the work Evangelos Michelakis is doing. I bet a good strategy to get in under the radar and colaberate and get inside information on this work would be to sponsor and send some highly qualified grad students to the Universtiy of Alberta as students and such. It would probobly look good on a resume as well for them. Our universtiy is having a recruitment drive for students and we have a limited budget for recruiting. Alberta oil companies are paying a lot for labour so we have less students and more openings here. (uofa has really only itself to blame there, with incremental contributions). Anyhow if you decide to come study here buy some local clothes for the cooler parts of the year. -- http://www.ualberta.ca/ ---Stanely Marcinkowski Student UofA, computer science |
|
|
Alert | IP |
Printer-friendly page | Edit |
Reply |
Reply With Quote | Top |
|
|
- RE: University Of Alberta,
Sandra, Mar-22-07, 10:34 PM, (1)
- RE: University Of Alberta,
IronRyan
, Mar-25-07, 10:46 PM, (2)
- RE: University Of Alberta,
mar dine, Mar-26-07, 00:38 AM, (3)
- RE: University Of Alberta,
Sandra, Mar-26-07, 02:54 AM, (5)
- RE: University Of Alberta lipoic acid study,
oracle, Sep-14-07, 05:23 PM, (7)
- RE: University Of Alberta,
jamesawick, Oct-02-08, 11:57 PM, (10)
|
IronRyan

unregistered user
|
Mar-25-07, 10:46 PM (PST) |
|
|
2. "RE: University Of Alberta"
In response to message #0
| |
U of A wasn't even the first one to use DCA in cancer research. If one was to listen to them, it would sound like he is the first person to ever think of it let alone do studies on it. Here are two patents that showed DCA used with lipoic acid where the DCA doubled the rate of tumor kill. United States Patent 6,331,559 Bingham , et al. December 18, 2001 Lipoic acid derivatives and their use in treatment of disease "... This second reagent is preferably an inhibitor of mitochondria energy metabolism and/or one that induces apoptosis. Such reagents include metabolism inhibitory reagents. Many such reagents are known in the art. One particularly preferred reagent is dichloroacetate. This second reagent may be administered sequentially, simultaneously or separately, so as to amplify patient response to said treatment method." and an example in an earlier patent: ..."This was tested in this Example with dichloroacetate (henceforth abbreviated DCA)(8)...." ..."We find that the cells of the experimental subset are killed approximately twice as rapidly as in the control subset."... The experimental subset had DCA while the standard had the lipoic acid by itself. ... So both of these patents I am sure also have studies associated with them that were published. Yet Dr. M doesn't have any of this noted in his work. Maybe he is just weak on research. Or maybe he is hedging his bet for money and fame. I find his inability to recognize earlier research appalling.
|
|
|
Alert | IP |
Printer-friendly page | Edit |
Reply |
Reply With Quote | Top |
|
|
 |
|
 |
|
 |
|
 |
|
 |
oracle
Member since Mar-17-07
128 posts |
Sep-14-07, 05:23 PM (PST) |
|
7. "RE: University Of Alberta lipoic acid study"
In response to message #2
 |
I FOUND THIS FROM 1997 so there is a lot of cool and awesoem power in these studies. http://altmedangel.com/polymva.htm Treating Cancer Without Injury Following is a description of a patented compound called Polydox or Poly-MVA which appears to meet the criteria of being non-toxic to normal cells yet lethal to malignant ones. Based on Warbrug's findings, in 1995, Merrill Garnett was issued a patent for a novel cancer chemotherapeutic agent which attacks a target which is only found in malignant cells and is related to specific changes in energy metabolism. This compound has been named Polydox (U.S. trials) or Poly-MVA (Canada & Mexico) or LAPd by some researchers. The MVA stands for minerals, vitamins and aminoacids. LAPd stands for Lipoic Acid / Palladium complex. Cancer is now considered a systematic, as opposed to a local, disease and its cause is multifactorial. Poly MVA attacks one of the root causes of cancer. It is a complex of lipoic acid, palladium, B12 and other B complex vitamins connected to a metal substrate. The complex is very soluble in water and fat. Therefore it travels all over the body and into every cell. It is classified as a nucleotide reductase. god bless O Oracle |
|
|
Alert | IP |
Printer-friendly page | Edit |
Reply |
Reply With Quote | Top |
|
|
|
 |
|
|
 |
|